NCT07181096 Frailty Among Renal Transplant Recipients and Relation to Chronic Allograft Dysfunction
| NCT ID | NCT07181096 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Alexandria University |
| Condition | Frailty |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-07-15 |
| Primary Completion | 2025-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-07-15 with a primary completion date of 2025-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to assess prevalence of frailty among renal transplant recipients in Alexandria University Hospitals and to study the relation between frailty and chronic allograft dysfunction.
Eligibility Criteria
Inclusion Criteria: * Renal transplanted patients with GFR more than 30 Exclusion Criteria: * Mentally or physically unfit patients. * Amputation of lower limb. * Active neoplasia, chronic liver disease, previous immunological disease. * Psychiatric disorders. * Pregnancy.
Contact & Investigator
Mohamed mamdouh Elsayed, MD
PRINCIPAL INVESTIGATOR
Associate professor
Frequently Asked Questions
Who can join the NCT07181096 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Frailty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07181096 currently recruiting?
Yes, NCT07181096 is actively recruiting participants. Contact the research team at dr_mohamedmamdouh87@yahoo.com for enrollment information.
Where is the NCT07181096 trial being conducted?
This trial is being conducted at Alexandria, Egypt.
Who is sponsoring the NCT07181096 clinical trial?
NCT07181096 is sponsored by Alexandria University. The principal investigator is Mohamed mamdouh Elsayed, MD at Associate professor. The trial plans to enroll 80 participants.